Rabbit Anti thymocyte globulin: Clinical Trials

2 trials of Rabbit Anti thymocyte globulin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Active not recruiting 1
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Rabbit Anti thymocyte globulin: new trials by email Literature Review of Rabbit Anti thymocyte globulin trials Research Report on Rabbit Anti thymocyte globulin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
Rabbit Anti thymocyte globulin, Busulfan, Fludarabine - AML, Childhood, Aml
Phase 1 / Phase 2RecruitingWashington University School of Medicine682024-11-152026-08-24
Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.
Cyclosporine, Mycophenolate mofetil (MMF), Rabbit Anti thymocyte globulin - Lung Transplantation, Allografts
Not applicableActive not recruitingVastra Gotaland Region2492016-10-122023-04-26

Conditions studied

Bronchiolitis Obliterans Syndrome (1)  ·  Leukemia, Myeloid, Acute (1)

Sponsors

Vastra Gotaland Region (1)  ·  Washington University School of Medicine (1)

Countries

Denmark (1)  ·  Finland (1)  ·  Norway (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Thomas M Pfeiffer, M.D. (1)

Results publications

PMID 37703908, PMID 40118141

NIH funding

2015 (1), 2019 (1)